R634W KIT Mutation in an Adult With Systemic Mastocytosis

被引:2
|
作者
Astle, John M. [1 ]
Rose, Michal G. [2 ,3 ]
Racke, Frederick K. [4 ]
Tormey, Christopher A. [5 ]
Siddon, Alexa J. [5 ,6 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Yale Univ, Sch Med, West Haven, CT 06516 USA
[3] Yale Univ, Canc Ctr, VA Connecticut Healthcare Syst, West Haven, CT USA
[4] Nichols Inst, Quest Diagnost, Hematol Oncol & Coagulat, San Juan Capistrano, CA USA
[5] Yale Univ, Dept Lab Med, Sch Med Pathol & Lab Med, VA Connecticut Healthcare Syst, West Haven, CT USA
[6] Yale Univ, Sch Med Pathol & Lab Med, Dept Pathol, VA Connecticut Healthcare Syst, West Haven, CT USA
关键词
urticaria; pigmentosa; familial; mutation; germline; mastocytosis; R634W; KIT; p.Arg634Trp; GASTROINTESTINAL STROMAL TUMORS; C-KIT; FAMILIAL MASTOCYTOSIS; PEDIATRIC MASTOCYTOSIS; GERMLINE MUTATION; MAST-CELLS; DOMAIN; DIAGNOSIS; IMATINIB;
D O I
10.1093/labmed/lmx026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Mastocytosis is a clonal neoplasm with the potential to affect various organs within the body. It can range in clinical severity from benign to extremely aggressive. Mastocytosis can be separated into cutaneous, systemic, and leukemic forms, as well as mast-cell sarcoma and extracutaneous mastocytoma. It is most often an acquired condition but can be inherited; the most commonly identified genetic aberrations leading to mastocytosis are activating mutations involving codon 816 of the KIT gene. Herein, we present the case of a 30-year-old Caucasian man with systemic mastocytosis discovered to have a p.Arg634Trp mutation involving KIT. To our knowledge, this mutation has previously only been identified in children with familial urticarial pigmentosa. Ours is the the first case report in the literature of an adult with systemic mastocytosis likely due to a p.Arg634Trp KIT mutation.
引用
收藏
页码:253 / 257
页数:5
相关论文
共 50 条
  • [1] Novel R634W c-kit Mutation Identified in Familial Mastocytosis
    Pollard, Whitney L.
    Beachkofsky, Thomas M.
    Kobayashi, Todd T.
    PEDIATRIC DERMATOLOGY, 2015, 32 (02) : 267 - 270
  • [2] Phenotypic Heterogeneity within Members of a Family Carrying the Same RBM20 Mutation R634W
    Pantou, Malena P.
    Gourzi, Polyxeni
    Gkouziouta, Aggeliki
    Tsiapras, Dimitrios
    Zygouri, Christianna
    Constantoulakis, Pantelis
    Adamopoulos, Stamatis
    Degiannis, Dimitrios
    CARDIOLOGY, 2018, 141 (03) : 150 - 155
  • [3] Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis
    Fritsche-Polanz, R
    Jordan, JH
    Feix, A
    Sperr, WR
    Sunder-Plassmann, G
    Valent, P
    Födinger, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 357 - 364
  • [4] Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
    Alvarez-Twose, Ivan
    Matito, Almudena
    Mario Morgado, Jose
    Sanchez-Munoz, Laura
    Jara-Acevedo, Maria
    Garcia-Montero, Andres
    Mayado, Andrea
    Caldas, Carolina
    Teodosio, Cristina
    Ignacio Munoz-Gonzalez, Javier
    Mollejo, Manuela
    Escribano, Luis
    Orfao, Alberto
    ONCOTARGET, 2017, 8 (40) : 68950 - 68963
  • [5] c-kit mutation in a population of patients with mastocytosis
    Nagata, H
    Okada, T
    Worobec, AS
    Semere, T
    Metcalfe, DD
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 113 (1-3) : 184 - 186
  • [6] Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype
    Chan, Eunice Ching
    Bai, Yun
    Kirshenbaum, Arnold S.
    Fischer, Elizabeth R.
    Simakova, Olga
    Bandara, Geethani
    Scott, Linda M.
    Wisch, Laura B.
    Cantave, Daly
    Carter, Melody C.
    Lewis, John C.
    Noel, Pierre
    Maric, Irina
    Gilfillan, Alasdair M.
    Metcalfe, Dean D.
    Wilson, Todd M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (01) : 178 - +
  • [7] Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
    de Melo Campos, Paula
    Machado-Neto, Joao A.
    Scopim-Ribeiro, Renata
    Visconte, Valeria
    Tabarroki, Ali
    Duarte, Adriana S. S.
    Barra, Flavia F. C.
    Vassalo, Jose
    Rogers, Heesun J.
    Lorand-Metze, Irene
    Tiu, Ramon V.
    Costa, Fernando F.
    Saad, Sara T. Olalla
    Traina, Fabiola
    LEUKEMIA RESEARCH, 2014, 38 (10) : 1245 - 1251
  • [8] A familial germline mutation in KIT associated with achalasia, mastocytosis and gastrointestinal stromal tumors shows response to kinase inhibitors
    Halpern, Alison L.
    Torphy, Robert J.
    McCarter, Martin D.
    Sciotto, Cosimo G.
    Glode, L. Michael
    Robinson, William A.
    CANCER GENETICS, 2019, 233 : 1 - 6
  • [9] Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis
    Wasag, Bartosz
    Niedoszytko, Marek
    Piskorz, Anna
    Lange, Magdalena
    Renke, Joanna
    Jassem, Ewa
    Biernat, Wojciech
    Debiec-Rychter, Maria
    Limon, Janusz
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : 859 - 865
  • [10] Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
    Verstovsek, Srdan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (02) : 89 - 98